Trial intelligence / Profile preview

PRP for Wound Healing in Abdominal Hysterectomy

NCT06298110Phase 3Not yet recruiting

Sponsor
Helwan University
Start
Mar 2024
Primary completion
Aug 2024
Modality
Adoptive Cell Transfer
01

Overview

Phase 3, randomised, open-label trial of autologous platelet-rich plasma in surgical wound (2 arms), sponsored by Helwan University. Primary endpoint: Changes in wound healing at Day 30. Planned start Mar 2024; status: not yet recruiting.

02

Drugs

autologous platelet-rich plasma
03

Conditions

surgical wound

Beyond the preview

Go deeper on NCT06298110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06298110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call